Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Harris

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|April 1, 1989
Clinical pharmacology of 5-fluorouracilR B Diasio, B E Harris
Pharmacology & Therapeutics|January 1, 1990
Metabolism of pyrimidine analogues and their nucleosidesG C Daher, B E Harris, R B Diasio
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
Cancer Research|January 1, 1990
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusionB E Harris, R Song, S J Soong, et al.
Cancer Research|December 1, 1989
Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liverB E Harris, R L Song, S J Soong, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1986
Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microfloraB E Harris, B W Manning, T W Federle, et al.
Journal of Biomedical Materials Research|March 1, 1985
Pyruvic acid as an etching agent in clinical dentistryD H Retief, B E Harris, E L Bradley, et al.
Cancer Research|June 1, 1983
Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinomaB E Harris, T P Pretlow, E L Bradley, et al.
Biochemical Pharmacology|December 15, 1988
Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapyB E Harris, R L Song, Y J He, et al.
Cancer Research|January 1, 1985
Enzyme activities in prostatic carcinoma related to Gleason gradesT G Pretlow, B E Harris, E L Bradley, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|April 1, 1989
Clinical pharmacology of 5-fluorouracilR B Diasio, B E Harris
Pharmacology & Therapeutics|January 1, 1990
Metabolism of pyrimidine analogues and their nucleosidesG C Daher, B E Harris, R B Diasio
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
Cancer Research|January 1, 1990
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusionB E Harris, R Song, S J Soong, et al.
Cancer Research|December 1, 1989
Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liverB E Harris, R L Song, S J Soong, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1986
Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microfloraB E Harris, B W Manning, T W Federle, et al.
Journal of Biomedical Materials Research|March 1, 1985
Pyruvic acid as an etching agent in clinical dentistryD H Retief, B E Harris, E L Bradley, et al.
Cancer Research|June 1, 1983
Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinomaB E Harris, T P Pretlow, E L Bradley, et al.
Biochemical Pharmacology|December 15, 1988
Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapyB E Harris, R L Song, Y J He, et al.
Cancer Research|January 1, 1985
Enzyme activities in prostatic carcinoma related to Gleason gradesT G Pretlow, B E Harris, E L Bradley, et al.
Pageof 1